FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis

CARLSBAD, Calif.--(BUSINESS WIRE)--ASI’s GenASIs automated scanning and image analysis system for detection and quantifying chromosome 17 and the HER-2/neu gene has been cleared by FDA for marketing in the US.

Feed Date: 
February 20, 2012